BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18340649)

  • 1. Role for epithelial dysregulation in early-onset colitis-associated colon cancer in Gi2-alpha-/- mice.
    Edwards RA; Wang K; Davis JS; Birnbaumer L
    Inflamm Bowel Dis; 2008 Jul; 14(7):898-907. PubMed ID: 18340649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Models of Inflammatory Bowel Disease and Colitis-Associated Cancer.
    Fung KY; Putoczki T
    Methods Mol Biol; 2018; 1725():3-13. PubMed ID: 29322404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gi2 alpha protein deficiency: a model of inflammatory bowel disease.
    Rudolph U; Finegold MJ; Rich SS; Harriman GR; Srinivasan Y; Brabet P; Bradley A; Birnbaumer L
    J Clin Immunol; 1995 Nov; 15(6 Suppl):101S-105S. PubMed ID: 8613481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice.
    Zhao J; Bulek K; Gulen MF; Zepp JA; Karagkounis G; Martin BN; Zhou H; Yu M; Liu X; Huang E; Fox PL; Kalady MF; Markowitz SD; Li X
    Gastroenterology; 2015 Dec; 149(7):1860-1871.e8. PubMed ID: 26344057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between T(h)1 and T(h)17 effector T-cell pathways in the pathogenesis of spontaneous colitis and colon cancer in the Gαi2-deficient mouse.
    Götlind YY; Fritsch Fredin M; Kumawat AK; Strid H; Willén R; Rangel I; Bland PW; Hörnquist EH
    Int Immunol; 2013 Jan; 25(1):35-44. PubMed ID: 22962436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice.
    Cho SJ; Kim JS; Kim JM; Lee JY; Jung HC; Song IS
    Int J Cancer; 2008 Aug; 123(4):951-7. PubMed ID: 18521906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulated claudin-1 expression promotes colitis-associated cancer by promoting β-catenin phosphorylation and activation in Notch/p-AKT-dependent manner.
    Gowrikumar S; Ahmad R; Uppada SB; Washington MK; Shi C; Singh AB; Dhawan P
    Oncogene; 2019 Jun; 38(26):5321-5337. PubMed ID: 30971761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMI1 and MEL18 Promote Colitis-Associated Cancer in Mice via REG3B and STAT3.
    Liu X; Wei W; Li X; Shen P; Ju D; Wang Z; Zhang R; Yang F; Chen C; Cao K; Zhu G; Chen H; Chen L; Sui J; Zhang E; Wu K; Wang F; Zhao L; Xi R
    Gastroenterology; 2017 Dec; 153(6):1607-1620. PubMed ID: 28780076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6.
    Vetrano S; Borroni EM; Sarukhan A; Savino B; Bonecchi R; Correale C; Arena V; Fantini M; Roncalli M; Malesci A; Mantovani A; Locati M; Danese S
    Gut; 2010 Feb; 59(2):197-206. PubMed ID: 19846409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons from genetic models of inflammatory bowel disease.
    Podolsky DK
    Acta Gastroenterol Belg; 1997; 60(2):163-5. PubMed ID: 9260328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-31 Reduces Inflammatory Signaling and Promotes Regeneration in Colon Epithelium, and Delivery of Mimics in Microspheres Reduces Colitis in Mice.
    Tian Y; Xu J; Li Y; Zhao R; Du S; Lv C; Wu W; Liu R; Sheng X; Song Y; Bi X; Li G; Li M; Wu X; Lou P; You H; Cui W; Sun J; Shuai J; Ren F; Zhang B; Guo M; Hou X; Wu K; Xue L; Zhang H; Plikus MV; Cong Y; Lengner CJ; Liu Z; Yu Z
    Gastroenterology; 2019 Jun; 156(8):2281-2296.e6. PubMed ID: 30779922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of colon-infiltrating γδ T cells in chronic inflammatory bowel disease and in colitis-associated cancer.
    Lo Presti E; Mocciaro F; Mitri RD; Corsale AM; Di Simone M; Vieni S; Scibetta N; Unti E; Dieli F; Meraviglia S
    J Leukoc Biol; 2020 Aug; 108(2):749-760. PubMed ID: 32202356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial derived-matrix metalloproteinase (MMP9) exhibits a novel defensive role of tumor suppressor in colitis associated cancer by activating MMP9-Notch1-ARF-p53 axis.
    Walter L; Pujada A; Bhatnagar N; Bialkowska AB; Yang VW; Laroui H; Garg P
    Oncotarget; 2017 Jan; 8(1):364-378. PubMed ID: 27861153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colonic Epithelial Surfactant Protein D Expression Correlates with Inflammation in Clinical Colonic Inflammatory Bowel Disease.
    Nexoe AB; Pilecki B; Von Huth S; Husby S; Pedersen AA; Detlefsen S; Marcussen N; Moeller JB; Holmskov U; Sorensen GL
    Inflamm Bowel Dis; 2019 Jul; 25(8):1349-1356. PubMed ID: 30753482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, B-catenin and p53 expression and the role of inflammation.
    Cooper HS; Murthy S; Kido K; Yoshitake H; Flanigan A
    Carcinogenesis; 2000 Apr; 21(4):757-68. PubMed ID: 10753213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients.
    Torres C; Antonioli D; Odze RD
    Am J Surg Pathol; 1998 Mar; 22(3):275-84. PubMed ID: 9500769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment with anti-alpha 4 integrin antibodies aggravates colitis in G alpha i2-deficient mice.
    Bjursten M; Bland PW; Willén R; Hörnquist EH
    Eur J Immunol; 2005 Aug; 35(8):2274-83. PubMed ID: 16052630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
    He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
    Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.